{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:37:06Z","timestamp":1790829426577,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:00:00Z","timestamp":1749945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["esmogastro.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Gastrointestinal Oncology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.esmogo.2025.100204","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:22:14Z","timestamp":1756480934000},"page":"100204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The increasing burden of early-onset pancreatic and biliary tract cancers: a review of risk factors"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-4909","authenticated-orcid":false,"given":"A.","family":"Boil\u00e8ve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7574-9364","authenticated-orcid":false,"given":"M.","family":"Brugel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7147-6936","authenticated-orcid":false,"given":"M.","family":"R\u00e9mond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7787-6911","authenticated-orcid":false,"given":"M.","family":"Val\u00e9ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ducreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2282-0101","authenticated-orcid":false,"given":"A.","family":"Turpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Smolenschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmogo.2025.100204_bib1","series-title":"Surveillance, Epidemiology, and End Results Program","year":"2024"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100204_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"10.1016\/j.esmogo.2025.100204_bib3","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100204_bib4","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2023.01.022","article-title":"Increasing pancreatic cancer incidence in young women in the United States: a population-based time-trend analysis, 2001-2018","volume":"164","author":"Abboud","year":"2023","journal-title":"Gastroenterology"},{"issue":"20","key":"10.1016\/j.esmogo.2025.100204_bib5","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1001\/jama.2021.18859","article-title":"Incidence of pancreatic cancer by age and sex in the US, 2000-2018","volume":"326","author":"Gaddam","year":"2021","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.esmogo.2025.100204_bib6","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","article-title":"Embracing cancer complexity: hallmarks of systemic disease","volume":"187","author":"Swanton","year":"2024","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100204_bib7","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/S2468-2667(18)30267-6","article-title":"Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry","volume":"4","author":"Sung","year":"2019","journal-title":"Lancet Public Health"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100204_bib8","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1158\/2159-8290.CD-22-1038","article-title":"Early-onset cancer in the gastrointestinal tract is on the rise\u2014evidence and implications","volume":"13","author":"Ben-Aharon","year":"2023","journal-title":"Cancer Discov"},{"issue":"5","key":"10.1016\/j.esmogo.2025.100204_bib9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00423-019-01810-0","article-title":"Early-onset pancreatic cancer: a population-based study using the SEER registry","volume":"404","author":"Ansari","year":"2019","journal-title":"Langenbecks Arch Surg"},{"issue":"4","key":"10.1016\/j.esmogo.2025.100204_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S2468-1253(23)00039-0","article-title":"Cause for concern: the rising incidence of early-onset pancreatic cancer","volume":"8","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100204_bib12","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1158\/1055-9965.EPI-21-0265","article-title":"Incidence and mortality of cancers of the biliary tract, gallbladder, and liver by sex, age, race\/ethnicity, and stage at diagnosis: United States, 2013 to 2017","volume":"30","author":"Ellington","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100204_bib13","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.esmogo.2025.100204_bib14","author":"Defossez"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100204_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.28171","article-title":"Patterns in cancer incidence among people younger than 50 years in the US, 2010 to 2019","volume":"6","author":"Koh","year":"2023","journal-title":"JAMA Network Open"},{"issue":"10","key":"10.1016\/j.esmogo.2025.100204_bib16","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/ijc.30273","article-title":"Early onset pancreatic malignancies: clinical characteristics and survival associations","volume":"139","author":"Beeghly-Fadiel","year":"2016","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1016\/j.esmogo.2025.100204_bib17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrgastro.2009.177","article-title":"Epidemiology of pancreatic cancer: an overview","volume":"6","author":"Raimondi","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.esmogo.2025.100204_bib18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1158\/1055-9965.EPI-05-0734","article-title":"Pancreatic cancer genetic epidemiology consortium","volume":"15","author":"Petersen","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.esmogo.2025.100204_bib19","article-title":"Molecular differences with therapeutic implications in early-onset compared with average-onset biliary tract cancers","volume":"8","author":"Jayakrishnan","year":"2024","journal-title":"JCO Precis Oncol"},{"issue":"7","key":"10.1016\/j.esmogo.2025.100204_bib20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.annonc.2022.03.276","article-title":"The age-dependent association of risk factors with pancreatic cancer","volume":"33","author":"Yuan","year":"2022","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100204_bib21","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/ijc.33004","article-title":"Genome-wide association study identifies an early onset pancreatic cancer risk locus","volume":"147","author":"Campa","year":"2020","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100204_bib22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MPA.0000000000000392","article-title":"Risk factors for early-onset and very-early-onset pancreatic adenocarcinoma: a pancreatic cancer case-control consortium (PanC4) analysis","volume":"45","author":"McWilliams","year":"2016","journal-title":"Pancreas"},{"issue":"10","key":"10.1016\/j.esmogo.2025.100204_bib23","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.dld.2023.02.023","article-title":"Genetic and non-genetic risk factors for early-onset pancreatic cancer","volume":"55","author":"Nodari","year":"2023","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100204_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.2040-1124.2012.00237.x","article-title":"Research on the relationships between pancreatic cancer and hyperglycemia in Chinese populations","volume":"4","author":"Huang","year":"2013","journal-title":"J Diabetes Investig"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100204_bib25","first-page":"9416","article-title":"Risk factors for early-onset pancreatic cancer patients, and survival analysis","volume":"10","author":"Jiang","year":"2017","journal-title":"Int J Clin Exp Med"},{"issue":"24","key":"10.1016\/j.esmogo.2025.100204_bib26","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1001\/jama.2009.886","article-title":"Body mass index and risk, age of onset, and survival in patients with pancreatic cancer","volume":"301","author":"Li","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.esmogo.2025.100204_bib27","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0016-5085(03)00272-5","article-title":"Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds","volume":"124","author":"Rulyak","year":"2003","journal-title":"Gastroenterology"},{"issue":"suppl 4","key":"10.1016\/j.esmogo.2025.100204_bib28","doi-asserted-by":"crossref","first-page":"iv79","DOI":"10.1093\/annonc\/mdz155.289","article-title":"Comparative analyses between younger and older patients with pancreatic adenocarcinoma: differences in clinicopathological features, treatment patterns, and outcomes","volume":"30","author":"Salem","year":"2019","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.esmogo.2025.100204_bib29","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/MPA.0000000000000636","article-title":"Clinicopathological characteristics of young patients with pancreatic cancer: an analysis of data from Pancreatic Cancer Registry of Japan Pancreas Society","volume":"45","author":"Eguchi","year":"2016","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100204_bib30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.21614\/chirurgia.113.3.405","article-title":"Very early onset pancreatic adenocarcinoma\u2014clinical presentation, risk factors and therapeutic options","volume":"113","author":"Bunduc","year":"2018","journal-title":"Chirurgia"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100204_bib31","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1158\/1055-9965.EPI-07-0341","article-title":"Early onset pancreatic cancer: evidence of a major role for smoking and genetic factors","volume":"16","author":"Raimondi","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100204_bib32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/MPA.0000000000000494","article-title":"Investigating physical activity in the etiology of pancreatic cancer: the age at which this is measured is important and is independent of body mass index","volume":"45","author":"Noor","year":"2016","journal-title":"Pancreas"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100204_bib33","first-page":"1005","article-title":"Is tropical pancreatitis premalignant?","volume":"87","author":"Augustine","year":"1992","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100204_bib34","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/MCG.0b013e3182a9f879","article-title":"Pancreatitis before pancreatic cancer: clinical features and influence on outcome","volume":"48","author":"Dzeletovic","year":"2014","journal-title":"J Clin Gastroenterol"},{"issue":"11","key":"10.1016\/j.esmogo.2025.100204_bib35","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1093\/annonc\/mds140","article-title":"Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4)","volume":"23","author":"Duell","year":"2012","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100204_bib36","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100204_bib37","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00592-016-0893-6","article-title":"Insulin resistance is associated with the aggressiveness of pancreatic ductal carcinoma","volume":"53","author":"Dugnani","year":"2016","journal-title":"Acta Diabetol"},{"issue":"11","key":"10.1016\/j.esmogo.2025.100204_bib38","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.cgh.2006.06.024","article-title":"New-onset diabetes and pancreatic cancer","volume":"4","author":"Gupta","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100204_bib39","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jhbp.776","article-title":"Risk factors and characteristics of young patients with the biliary tract carcinoma: results of a project study for biliary surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery","volume":"27","author":"Ariake","year":"2020","journal-title":"J Hepatobiliary-Pancreat Sci"},{"issue":"5","key":"10.1016\/j.esmogo.2025.100204_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"15","key":"10.1016\/j.esmogo.2025.100204_bib41","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1158\/0008-5472.CAN-19-0459","article-title":"Anthropometric risk factors for cancers of the biliary tract in the biliary tract cancers pooling project","volume":"79","author":"Jackson","year":"2019","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100204_bib42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000453013","article-title":"Epidemiology and risk factors of cholangiocarcinoma","volume":"32","author":"Kirstein","year":"2016","journal-title":"Visc Med"},{"issue":"12","key":"10.1016\/j.esmogo.2025.100204_bib43","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/jnci\/djz103","article-title":"Smoking, alcohol, and biliary tract cancer risk: a pooling project of 26 prospective studies","volume":"111","author":"McGee","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.esmogo.2025.100204_bib45","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrc3220","article-title":"Developmental reprogramming of cancer susceptibility","volume":"12","author":"Walker","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100204_bib46","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1152\/physrev.00002.2020","article-title":"Developmental origins of metabolic diseases","volume":"101","author":"Hoffman","year":"2021","journal-title":"Physiol Rev"},{"issue":"7955","key":"10.1016\/j.esmogo.2025.100204_bib47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41586-023-05874-3","article-title":"Lung adenocarcinoma promotion by air pollutants","volume":"616","author":"Hill","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100204_bib48","doi-asserted-by":"crossref","DOI":"10.1289\/EHP9620","article-title":"Exposure to outdoor particulate matter air pollution and risk of gastrointestinal cancers in adults: a systematic review and meta-analysis of epidemiologic evidence","volume":"130","author":"Pritchett","year":"2022","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.esmogo.2025.100204_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.111608","article-title":"The association between ambient air pollutants and pancreatic cancer in the Multiethnic Cohort Study","volume":"202","author":"Bogumil","year":"2021","journal-title":"Environ Res"},{"key":"10.1016\/j.esmogo.2025.100204_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.115246","article-title":"Various ambient air pollutants, residential green spaces, fibrosis 4 scores, genetic susceptibility, and risk of severe liver disease","volume":"263","author":"Ye","year":"2023","journal-title":"Ecotoxicol Environ Saf"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100204_bib51","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00420-021-01773-0","article-title":"The impact of particulate matter 2.5 on the risk of hepatocellular carcinoma: a meta-analysis","volume":"95","author":"Wu","year":"2022","journal-title":"Int Arch Occup Environ Health"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100204_bib52","first-page":"281","article-title":"Household cooking fuel and gallbladder cancer risk: a multi-centre case\u2013control study in India","volume":"35","author":"Shridhar","year":"2024","journal-title":"Cancer Causes Control"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100204_bib53","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrendo.2011.56","article-title":"Endocrine disruptors in the etiology of type 2 diabetes mellitus","volume":"7","author":"Alonso-Magdalena","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"10.1016\/j.esmogo.2025.100204_bib54","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ueg2.12602","article-title":"Association between pancreatic adenocarcinoma risk and concentration of organochlorine pesticides in adipose tissue and urine: a targeted-screening analysis case-control study (PESTIPAC)","volume":"12","author":"Brugel","year":"2024","journal-title":"United European Gastroenterol J"},{"issue":"12","key":"10.1016\/j.esmogo.2025.100204_bib55","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.dld.2022.08.023","article-title":"Pesticides and pancreatic adenocarcinoma: a transversal epidemiological, environmental and mechanistic narrative review","volume":"54","author":"Brugel","year":"2022","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100204_bib56","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/ije\/dyab115","article-title":"Plasma concentrations of persistent organic pollutants and pancreatic cancer risk","volume":"51","author":"Porta","year":"2022","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.esmogo.2025.100204_bib57","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.fct.2018.06.014","article-title":"Glyphosate induces growth of estrogen receptor alpha positive cholangiocarcinoma cells via non-genomic estrogen receptor\/ERK1\/2 signaling pathway","volume":"118","author":"Sritana","year":"2018","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100204_bib58","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41370-018-0094-1","article-title":"A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects","volume":"29","author":"Sunderland","year":"2019","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"10.1016\/j.esmogo.2025.100204_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.117036","article-title":"Time trends in per- and polyfluoroalkyl substances (PFAS) concentrations in the Danish population: a review based on published and newly analyzed data","volume":"237","author":"Hull","year":"2023","journal-title":"Environ Res"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100204_bib60","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1470-2045(23)00622-8","article-title":"Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid","volume":"25","author":"Zahm","year":"2024","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.esmogo.2025.100204_bib61","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/carcin\/bgac005","article-title":"Exposure to perfluorooctanoic acid leads to promotion of pancreatic cancer","volume":"43","author":"Kamendulis","year":"2022","journal-title":"Carcinogenesis"},{"issue":"10","key":"10.1016\/j.esmogo.2025.100204_bib62","doi-asserted-by":"crossref","DOI":"10.1289\/EHP13208","article-title":"Nested case\u2013control studies investigating serum perfluorooctanoate and perfluorooctane sulfonate levels and pancreatic ductal adenocarcinoma in two cohorts","volume":"131","author":"Zhang","year":"2023","journal-title":"Environ Health Perspect"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100204_bib63","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41368-018-0018-x","article-title":"The oral microbiome bank of China","volume":"10","author":"Xian","year":"2018","journal-title":"Int J Oral Sci"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100204_bib64","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/cells12030370","article-title":"Any role for microbiota in cholangiocarcinoma? A comprehensive review","volume":"12","author":"Elvevi","year":"2023","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100204_bib65","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1186\/gb-2012-13-6-r42","article-title":"Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples","volume":"13","author":"Segata","year":"2012","journal-title":"Genome Biol"},{"issue":"5","key":"10.1016\/j.esmogo.2025.100204_bib66","doi-asserted-by":"crossref","first-page":"G602","DOI":"10.1152\/ajpgi.00230.2019","article-title":"Dysbiosis: from fiction to function","volume":"317","author":"Tiffany","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.esmogo.2025.100204_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1208044","article-title":"The gut dysbiosis-cancer axis: illuminating novel insights and implications for clinical practice","volume":"14","author":"Asseri","year":"2023","journal-title":"Front Pharmacol"},{"issue":"6391","key":"10.1016\/j.esmogo.2025.100204_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome\u2013mediated bile acid metabolism regulates liver cancer via NKT cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.esmogo.2025.100204_bib69","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1038\/s41467-021-27112-y","article-title":"Dysbiosis of human gut microbiome in young-onset colorectal cancer","volume":"12","author":"Yang","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100204_bib70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1158\/1940-6207.CAPR-23-0091","article-title":"Early-onset colon cancer shows a distinct intestinal microbiome and a host\u2013microbe interaction","volume":"17","author":"Adnan","year":"2024","journal-title":"Cancer Prev Res"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100204_bib71","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1159\/000516689","article-title":"Gut microbiota profiles in early- and late-onset colorectal cancer: a potential diagnostic biomarker in the future","volume":"102","author":"Abdullah","year":"2021","journal-title":"Digestion"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100204_bib72","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1136\/gutjnl-2022-327156","article-title":"Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer","volume":"72","author":"Kong","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100204_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.03.035","article-title":"Gut microbiota modulate CD8 T cell responses to influence colitis-associated tumorigenesis","volume":"31","author":"Yu","year":"2020","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.esmogo.2025.100204_bib74","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/2159-8290.CD-20-0304","article-title":"Gut microbiome directs hepatocytes to recruit MDSCs and promote cholangiocarcinoma","volume":"11","author":"Zhang","year":"2021","journal-title":"Cancer Discov"},{"issue":"7","key":"10.1016\/j.esmogo.2025.100204_bib75","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41579-018-0029-9","article-title":"Best practices for analysing microbiomes","volume":"16","author":"Knight","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100204_bib76","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/hep.30852","article-title":"Characterization of gut microbiota, bile acid metabolism, and cytokines in intrahepatic cholangiocarcinoma","volume":"71","author":"Jia","year":"2020","journal-title":"Hepatology"},{"issue":"16","key":"10.1016\/j.esmogo.2025.100204_bib77","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.3390\/ijms22168882","article-title":"Targeting cytokines, pathogen-associated molecular patterns, and damage-associated molecular patterns in sepsis via blood purification","volume":"22","author":"Moriyama","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100204_bib78","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000292","article-title":"Association of chronic opisthorchis infestation and microbiota alteration on tumorigenesis in cholangiocarcinoma","volume":"12","author":"Ketpueak","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100204_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/srep42744","article-title":"Elevated prevalence of Helicobacter species and virulence factors in opisthorchiasis and associated hepatobiliary disease","volume":"7","author":"Deenonpoe","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.esmogo.2025.100204_bib80","article-title":"In sickness and in health: the relationships between bacteria and bile in the human gut","volume":"96","author":"Hay","year":"2016"},{"issue":"21","key":"10.1016\/j.esmogo.2025.100204_bib81","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.3390\/cancers14215379","article-title":"Dysbiosis of the fecal and biliary microbiota in biliary tract cancer","volume":"14","author":"Ito","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100204_bib82","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12072-021-10279-3","article-title":"Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer","volume":"16","author":"Deng","year":"2022","journal-title":"Hepatol Int"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100204_bib83","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.3390\/microorganisms11092363","article-title":"Gut microbiota in diagnosis, therapy and prognosis of cholangiocarcinoma and gallbladder carcinoma\u2014a scoping review","volume":"11","author":"Lederer","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.esmogo.2025.100204_bib84","article-title":"Alterations of gut mycobiota profiles in intrahepatic cholangiocarcinoma","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Microbiol"},{"issue":"12","key":"10.1016\/j.esmogo.2025.100204_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.634","article-title":"Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease","volume":"11","author":"Yu","year":"2021","journal-title":"Clin Transl Med"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100204_bib86","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/mbo3.218","article-title":"Characterization of the bile and gall bladder microbiota of healthy pigs","volume":"3","author":"Jim\u00e9nez","year":"2014","journal-title":"Microbiology Open"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100204_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.97","article-title":"A metagenomic study of biliary microbiome change along the cholecystitis-carcinoma sequence","volume":"10","author":"Song","year":"2020","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100204_bib88","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-nutr-082018-124306","article-title":"Pancreas\u2013microbiota cross talk in health and disease","volume":"39","author":"Adolph","year":"2019","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.esmogo.2025.100204_bib89","series-title":"The Gastrointestinal System: Gastrointestinal, Nutritional and Hepatobiliary Physiology","author":"Leung","year":"2014"},{"issue":"56","key":"10.1016\/j.esmogo.2025.100204_bib90","doi-asserted-by":"crossref","first-page":"95176","DOI":"10.18632\/oncotarget.18820","article-title":"Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China","volume":"8","author":"Ren","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.esmogo.2025.100204_bib91","article-title":"Intratumor microbiome analysis identifies positive association between Megasphaera and survival of Chinese patients with pancreatic ductal adenocarcinomas","volume":"13","author":"Huang","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.esmogo.2025.100204_bib92","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100204_bib93","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1097\/JS9.0000000000001724","article-title":"Gut microbiome changes associated with chronic pancreatitis and pancreatic cancer: a systematic review and meta-analysis","volume":"110","author":"Hong","year":"2024","journal-title":"Int J Surg"},{"issue":"6356","key":"10.1016\/j.esmogo.2025.100204_bib94","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100204_bib95","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/carcin\/bgy073","article-title":"Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models","volume":"39","author":"Thomas","year":"2018","journal-title":"Carcinogenesis"},{"issue":"9","key":"10.1016\/j.esmogo.2025.100204_bib96","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.18632\/oncotarget.3109","article-title":"Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis","volume":"6","author":"Mitsuhashi","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.esmogo.2025.100204_bib97","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.semcancer.2021.05.027","article-title":"A comprehensive review of the multifaceted role of the microbiota in human pancreatic carcinoma","volume":"86","author":"Pandya","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"10.1016\/j.esmogo.2025.100204_bib98","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"issue":"suppl 16","key":"10.1016\/j.esmogo.2025.100204_bib99","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1200\/JCO.2024.42.16_suppl.4016","article-title":"Tumor microbiome differences in early-onset versus average-onset pancreatic adenocarcinoma","volume":"42","author":"Jayakrishnan","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmogo.2025.100204_bib100","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.1373","article-title":"Characterization of the salivary microbiome in patients with pancreatic cancer","volume":"3","author":"Torres","year":"2015","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100204_bib101","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/gutjnl-2016-312580","article-title":"Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study","volume":"67","author":"Fan","year":"2018","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100204_bib102","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2320280","article-title":"Roles of microbiota in pancreatic cancer development and treatment","volume":"16","author":"Cruz","year":"2024","journal-title":"Gut Microbes"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100204_bib103","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/liv.15922","article-title":"Management of biliary tract cancers in early-onset patients: a nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort","volume":"44","author":"Lebeaud","year":"2024","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.esmogo.2025.100204_bib104","doi-asserted-by":"crossref","DOI":"10.1200\/PO.22.00594","article-title":"The cholangiocarcinoma in the young (CITY) study: tumor biology, treatment patterns, and survival outcomes in adolescent young adults with cholangiocarcinoma","author":"Pappas","year":"2023","journal-title":"JCO Precis Oncol"},{"issue":"5","key":"10.1016\/j.esmogo.2025.100204_bib105","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1245\/s10434-024-15013-5","article-title":"Early onset intrahepatic cholangiocarcinoma: clinical characteristics, oncological outcomes, and genomic\/transcriptomic features","volume":"31","author":"Tsilimigras","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.esmogo.2025.100204_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113338","article-title":"Clinical and genomic characterisation of early-onset pancreatic cancer","volume":"194","author":"Castet","year":"2023","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.esmogo.2025.100204_bib107","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/ijc.35135","article-title":"Clinical and molecular features of early onset pancreatic adenocarcinoma","volume":"155","author":"R\u00e9mond","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.esmogo.2025.100204_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.751795","article-title":"A predictive model based on the gut microbiota improves the diagnostic effect in patients with cholangiocarcinoma","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Cell Infect Microbiol"}],"container-title":["ESMO Gastrointestinal Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819825000731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819825000731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T10:02:22Z","timestamp":1758189742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949819825000731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":106,"alternative-id":["S2949819825000731"],"URL":"https:\/\/doi.org\/10.1016\/j.esmogo.2025.100204","relation":{},"ISSN":["2949-8198"],"issn-type":[{"value":"2949-8198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The increasing burden of early-onset pancreatic and biliary tract cancers: a review of risk factors","name":"articletitle","label":"Article Title"},{"value":"ESMO Gastrointestinal Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmogo.2025.100204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100204"}}